ReadYourDNA

Tenofovir (Viread)

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Tenofovir

What it is

Tenofovir is an antiviral of the NRTI group (nucleotide reverse transcriptase inhibitors): it is built into viral DNA as it is copied and stops the chain from growing. It is used for HIV, in combination with other medicines and to prevent infection (PrEP), and for chronic hepatitis B. It is sold as Viread (tenofovir disoproxil, TDF) and in newer form as tenofovir alafenamide (TAF, Vemlidy), and in many combination tablets.

How genes come into it

Tenofovir is not broken down by liver enzymes; the kidneys clear it, pulling it into kidney cells with SLC22A6 (OAT1) and pumping it out with ABCC4 and ABCC2. Studies have linked variants in these transporters to tenofovir levels inside cells and to kidney side effects. The findings come from single or a few studies, and there is no CPIC or DPWG guideline.

What research found

Every published finding on gene variants and Tenofovir. Upload your DNA file to see which of these rows apply to you.

Rated evidence (17 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

ABCC2 rs717620: Level 3. Toxicity: HIV infectious disease. 5.

ABCC4 rs3742106: Level 3. Metabolism/PK: HIV infectious disease. 3.

ABCC4 rs1059751: Level 3. Toxicity: HIV infectious disease. 2.

ABCC2 rs17222723: Level 3. Toxicity: HIV infectious disease. 2.

Metabolism (51 findings)

Studies of how quickly the body processes this medication.

ABCC4 rs1059751: Genotypes AA + AG is associated with decreased concentrations of tenofovir in people with Hepatitis B, Chronic as compared to genotype GG.

ABCC4 rs3742106: Genotypes AC + CC is associated with increased concentrations of tenofovir in people with HIV Infections as compared to genotype AA.

ABCG2 rs2231142: Genotypes GT + TT are associated with increased concentrations of tenofovir in women with HIV Infections as compared to genotype GG.

IFNL3, IFNL4 rs12979860: Allele C is associated with increased clearance of tenofovir in people with HIV Infections as compared to allele T.

Response (1 finding)

Studies of how well it worked in people carrying a variant.

CYP2B6 rs2279343: Genotypes AG + GG is associated with increased clinical benefit to efavirenz, lamivudine and tenofovir in people with HIV Infections as compared to genotype AA.

Side effects (5 findings)

Studies of side effects in people carrying a variant.

ABCC4 rs1751034: Genotype TT is associated with increased concentrations of tenofovir in people with HIV Infections as compared to genotypes CC + CT.

ABCC4 rs3742106: Genotypes AC + CC are associated with increased concentrations of tenofovir in people with HIV Infections as compared to genotype AA.

ABCC2 rs2273697: Genotypes AA + AG is not associated with increased discontinuation of tenofovir in people with HIV Infections as compared to genotype GG.

ABCC2 rs717620: Genotypes CT + TT is not associated with increased discontinuation of tenofovir in people with HIV Infections as compared to genotype CC.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Emtriva (NRTIs)

Epivir (NRTIs)

NRTIs (class) (NRTIs)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com